Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

AN2 Therapeutics Enters into Collaboration with GSK to Advance Boron-Based Therapies for Tuberculosis

Tuesday, November 11, 2025

AN Therapeutics has entered into a research collaboration with GSK to develop new treatments for tuberculosis TB The Gates Foundation will provide an additional year of funding to support ANs work within this partnership

MeiraGTx Enters into Collaboration with Eli Lilly to Advance Genetic Medicines in Ophthalmology

Tuesday, November 11, 2025

MeiraGTx Holdings has entered into a strategic collaboration with Eli Lilly and Company to develop and commercialise genetic therapies targeting ophthalmic diseases

Kelun-Biotech Showcases Breakthrough TROP2 ADC Sacituzumab Tirumotecan Clinical Results at 2025 CCHIO Congress in Kunming

Monday, November 10, 2025

KelunBiotech presented pivotal clinical data for their innovative TROP ADC sacituzumab tirumotecan demonstrating strong efficacy and safety across solid tumor indications at the Chinese Congress on Holistic Integrative Oncology

CStone Pharmaceuticals Unveils CS2015 (OX40L/TSLP Bispecific Antibody) at ACAAI 2025, Advancing Asia's Leadership in Autoimmune Innovation

Friday, November 07, 2025

CStone Pharmaceuticals presents its novel autoimmune candidate CS OXLTSLP bispecific antibody at the ACAAI Annual Meeting showcasing advanced molecular design and scalable manufacturing for Asias biopharma sector

Johnson & Johnson’s DARZALEX FASPRO® Receives Approval for the Treatment of High-Risk Smouldering Multiple Myeloma

Friday, November 07, 2025

Johnson Johnson has announced that the United States Food and Drug Administration FDA has approved DARZALEX FASPRO daratumumab and hyaluronidasefihj as a singleagent therapy for adults with highrisk smouldering multiple myeloma HRSMM

Clariant Completes Strategic Expansion of Pharmaceutical Excipients and Specialty Chemicals Manufacturing in China

Thursday, November 06, 2025

Clariant has completed a major expansion of its Daya Bay facilities in China significantly boosting its manufacturing capabilities for pharmaceutical excipients and specialty chemicals across Asia

Jupiter Neurosciences Receives FDA Clearance to Begin Phase 2a Trial of JOTROL™ in Parkinson’s Disease

Thursday, November 06, 2025

Jupiter Neurosciences has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application to initiate a Phase a clinical study of JOTROL in patients with Parkinsons disease

Nona Biosciences Enters into Collaboration with Umoja Biopharma to Advance In Vivo CAR-T Cell Therapies

Thursday, November 06, 2025

Nona Biosciences has announced an expanded evaluation and licence agreement with Umoja Biopharma The new agreement builds upon the strategic partnership established between the two companies in September

4D Molecular Therapeutics and Otsuka Pharmaceutical Forge $421 Million Strategic Partnership to Develop and Commercialize Gene Therapy 4D-150 for Retinal Diseases in Asia-Pacific

Wednesday, November 05, 2025

Molecular Therapeutics DMT a biotechnology innovator specializing in gene therapy announced a highprofile strategic partnership with Japans Otsuka Pharmaceutical Co Ltd

Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting

Tuesday, November 04, 2025

Sumitomo Pharma America will present new clinical data for investigational treatments targeting relapsedrefractory acute myeloid leukemia and myelofibrosis at the upcoming American Society of Hematology Annual Meeting